SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism

Abroad (travel likely)RecruitingPHASE2

Conditions

Atrial Fibrillation (AF) · Hypertension

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Affiliated Huashan Hospital, Cardiology Department, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Liwen Bao, MD) · blw_betty@163.com · 86 13917073226

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation

Atrial Fibrillation · Obesity

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

Diabetes Mellitus · Atrial Fibrillation

Abroad (travel likely)RecruitingPHASE3

Oklahoma City, United States

SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF

Chronic Coronary Syndrome · Atrial Fibrillation

Abroad (travel likely)RecruitingPHASE3

Brno, Czechia · Aarhus, Denmark

Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly

Atrial Fibrillation (AF)

Abroad (travel likely)Recruiting

Beijing, China